Evidence map›Paper›PMID 34598312›Full record

ArticleTropical medicine & international health : TM & IH2021

Trends in fever case management for febrile inpatients in a low malaria incidence setting of Tanzania.

Deng B Madut, Matthew P Rubach, John P Bonnewell, Elena R Cutting, Manuela Carugati, Nathaniel Kalengo, Michael J Maze, Anne B Morrissey, Blandina T Mmbaga, Bingileki F Lwezaula and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Deng B MadutDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
Matthew P RubachDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
John P BonnewellDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
Elena R CuttingDuke University School of Medicine, Durham, North Carolina, USA.
Manuela CarugatiDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
Nathaniel KalengoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Michael J MazeDepartment of Medicine, University of Otago, Christchurch, New Zealand.
Anne B MorrisseyDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
Blandina T MmbagaKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Bingileki F LwezaulaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Grace KinaboKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Ronald MbwasiKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Kajiru G KilonzoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Venance P MaroKilimanjaro Christian Medical Centre, Moshi, Tanzania.
John A CrumpDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
Duke Medical Center · USDuke University · USKilimanjaro Christian Medical Centre · TZTumaini University · TZDuke Institute for Health Innovation · USSt. Francis Referral Hospital · TZUniversity of Otago · NZ

Funding

Ruth L. Kirschstein National Research Service Award (NRSA)- T32T32AI007392 · NIAID · DUKE UNIVERSITY · PI Amy Lynn Corneli, Guido Ferrari · 1990 to 2026
$9.8M
Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium-Expanding Diversity for Global Equity (EDGE)D43TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALIYU, MUKTAR HASSAN, HEIMBURGER, DOUGLAS CORBETT · 2017 to 2021
$6.3M
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
International Clinical Trials UnitU01AI062563 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2007
$4.0M
Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Viral Zoonoses and Severe Febrile Illness in Northern TanzaniaK23AI116869 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$896k
Biotechnology and Biological Sciences Research Council BB/J010367/1Biotechnology and Biological Sciences Research Council BB/L017679Biotechnology and Biological Sciences Research Council BB/L018845Biotechnology and Biological Sciences Research Council BB/L018926FIC NIH HHS D43 TW009337FIC NIH HHS R01 TW009237FIC NIH HHS R25 TW009337NIAID NIH HHS K23 AI116869NIAID NIH HHS R01 AI121378NIAID NIH HHS T32 AI007392NIAID NIH HHS U01 AI062563
6 · The paper itself

Abstract

objectivesIn 2010, WHO published guidelines emphasising parasitological confirmation of malaria before treatment. We present data on changes in fever case management in a low malaria transmission setting of northern Tanzania after 2010.

methodsWe compared diagnoses, treatments and outcomes from two hospital-based prospective cohort studies, Cohort 1 (2011-2014) and Cohort 2 (2016-2019), that enrolled febrile children and adults. All participants underwent quality-assured malaria blood smear-microscopy. Participants who were malaria smear-microscopy negative but received a diagnosis of malaria or received an antimalarial were categorised as malaria over-diagnosis and over-treatment, respectively.

resultsWe analysed data from 2098 participants. The median (IQR) age was 27 (3-43) years and 1047 (50.0%) were female. Malaria was detected in 23 (2.3%) participants in Cohort 1 and 42 (3.8%) in Cohort 2 (p = 0.059). Malaria over-diagnosis occurred in 334 (35.0%) participants in Cohort 1 and 190 (17.7%) in Cohort 2 (p < 0.001). Malaria over-treatment occurred in 528 (55.1%) participants in Cohort 1 and 196 (18.3%) in Cohort 2 (p < 0.001). There were 30 (3.1%) deaths in Cohort 1 and 60 (5.4%) in Cohort 2 (p = 0.007). All deaths occurred among smear-negative participants.

conclusionWe observed a substantial decline in malaria over-diagnosis and over-treatment among febrile inpatients in northern Tanzania between two time periods after 2010. Despite changes, some smear-negative participants were still diagnosed and treated for malaria. Our results highlight the need for continued monitoring of fever case management across different malaria epidemiological settings in sub-Saharan Africa.

Indexed as

InpatientsAdolescentAdultAntimalarialsChildChild, PreschoolCohort StudiesDiagnostic Tests, RoutineFemaleFeverHumansIncidenceMalariaMaleOverdiagnosisOvertreatmentAntimalarialsAfricaantimalarialsfevermalariaTanzania

Identifiers

PMID34598312
PMCPMC8639662
OpenAlexW3202528820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.